Trial no.:
|
PACTR202505573249191 |
Date of Approval:
|
19/05/2025 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Open Septorhinoplasty |
Official scientific title |
Comparative Study of Peizosurgery and Traditional Osteotomy in Open Septorhinoplasty |
Brief summary describing the background
and objectives of the trial
|
Lateral osteotomy is a key component of rhinoplasty, particularly when correcting nasal deformities or narrowing the nasal dorsum after hump removal. While effective in reshaping the nasal bones and addressing open roof deformities, traditional lateral osteotomy techniques often result in complications such as bleeding, bruising (ecchymosis), and prolonged postoperative swelling (edema). These adverse effects are largely due to soft tissue trauma and nasal mucosal injury caused by conventional mechanical instruments.
To overcome these limitations, piezosurgery has emerged as an innovative technique that uses ultrasonic vibrations to cut bone with high precision while preserving adjacent soft tissues. This approach minimizes intraoperative bleeding, reduces postoperative edema and ecchymosis, and improves patient comfort and recovery. Piezosurgery is particularly valuable in delicate surgical areas where bone lies close to soft tissue, such as the nasal pyramid.
Despite these advantages, literature reports vary on whether piezosurgery significantly outperforms conventional methods in all postoperative outcomes. The present study was conducted to compare piezosurgery with traditional osteotomy techniques in open septorhinoplasty. The investigation focused on evaluating each method’s reliability, complication rates, and both functional and aesthetic results to determine the most effective approach for lateral nasal osteotomy. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Ear, Nose and Throat |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Diagnosis / Prognosis |
Anticipated trial start date |
14/12/2021 |
Actual trial start date |
14/12/2021 |
Anticipated date of last follow up |
10/12/2024 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
40 |
Actual target sample size (number of participants) |
|
Recruitment status |
Completed |
Publication URL |
|
|